- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
David Newman, GlaxoSmithKline
S
David Newman
Senior Product Director, Tykerb, GlaxoSmithKline
NOTED FOR: Launch of oncology treatment Tykerb
EXCEEDED RESULTS: Treated 5,500 patients
On what motivates him to succeed:
We think we have it tough. But that's nothing compared to fighting breast cancer. These women help us put our work in perspective, and give us a sense of mission to not necessarily sell Tykerb, but instead make sure every patient gets its benefit of efficacy.
David Newman
In a therapeutic area like oncology, you have a chance to make a real difference. That focus is what keeps me motivated day in and day out.
Beyond the Birthrate: The Societal Costs of Maternal Mortality
September 6th 2024Head of Medical Affairs and Outcomes Research at Organon, Charlotte Owens, MD, FACOG, discusses the most critical changes needed to close the gaps in R&D for maternal health solutions and how feasible they are to make.
